NCT01754324View on ClinicalTrials.gov

The Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Neonatal Abstinence Syndrome
Interventions
DRUG

Methadone

The starting dose of the protocol is 0.05mg/kg by mouth given every 6 hours and gradually decreased in a stepwise, standardized fashion.

Trial Locations (2)

45229

The University Hospital, Cincinnati

45255

Mercy Hospital Anderson, Cincinnati

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT01754324 - The Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome | Biotech Hunter | Biotech Hunter